Follow‐up
Over 24 weeks, 22/400 (6%) participants moved out of study communities (12/197 intervention and 10/203 in control); additionally, one control participant died. Endpoint viral loads were obtained on 371/377 (98%) of the remaining participants: 181/185 (98%) intervention and 190/192 (99%) control. Endpoint PEth was obtained in 181/185 (98%) intervention and 188/192 (98%) control participants.